as on December 2, 2025 at 4:01 pm IST
Day's Low
Day's High
1.02%
Downside
4.58%
Upside
52 Week's Low
52 Week's High
61.87%
Downside
44.80%
Upside
as on December 2, 2025 at 4:01 pm IST
Market Cap
₹820.38 Cr
Return on Equity (ROE)
13.36
PE Ratio (TTM)
35.57
Return on capital employed (ROCE)
17.49
Industry PE ratio
42.47
Beta (LTM)
0P/B Ratio
2.4
Dividend Yield
0.47
PEG Ratio
-13.37
Quarterly Earnings Growth YOY
37.2
EPS (TTM)
22.11
Sector
Pharmaceuticals
Book Value
185.64
Technical Analysis
Bullish
View Technical Analysis
as on December 2, 2025 at 4:01 pm IST
Titan Biotech Ltd in the last 5 years
Lowest (3.20x)
June 30, 2020
Today (35.57x)
December 1, 2025
Industry (42.47x)
December 1, 2025
Highest (48.65x)
October 15, 2025
Today’s Price to Earnings Ratio: 35.57x
Compare market cap, revenue, PE, and other key metrics of Titan Biotech Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 820.38 | 135.42% | 0.51 | 18 | 156 | |
| NA | 526.79 | 16.06% | 0.00 | 13 | 104 | |
| NA | 25.51 | -17.39% | 0.00 | 2 | 22 | |
| BUY | 4,319.75 | 343.97% | 0.56 | 95 | 921 | |
| NA | 420.42 | 26.43% | 0.68 | 18 | 344 |
Search interest for Titan Biotech Ltd Stock has decreased by -47% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Titan Biotech Ltd.
Titan Biotech Ltd’s net profit jumped 15.82% since last year same period to ₹7.76Cr in the Q2 2025-2026. On a quarterly growth basis, Titan Biotech Ltd has generated 13.12% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Titan Biotech Ltd has declared dividend of ₹2.00 per share on 30 May 2025 - translating a dividend yield of 0.20%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
![]()
In the last 3 years, Titan Biotech has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 36.55 Cr → 55.68 Cr (in ₹), with an average increase of 18.9% per quarter
Retail Holding Up
![]()
Retail Investor have increased holdings from 44.09% to 44.19% in Sep 2025 quarter
Price Rise
![]()
In the last 3 months, Titan Biotech stock has moved up by 46.0%
Best in 1 Year
![]()
In the last 1 year, Titan Biotech has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Profit Spike
![]()
Netprofit is up for the last 3 quarters, 4.05 Cr → 7.76 Cr (in ₹), with an average increase of 26.3% per quarter
Promoter Holding Down
![]()
Promoters have decreased holdings from 55.88% to 55.78% in Sep 2025 quarter
| Organisation | Titan Biotech Ltd |
| Headquarters | New Delhi |
| Industry | Pharmaceuticals |
| CEO | Rohit Jain |
| E-voting on shares | Click here to vote |
Titan Biotech Ltd share price today stands at ₹980 as on at the close of the market. Titan Biotech Ltd share today touched a day high of ₹1024.9 and a low of ₹970.
Titan Biotech Ltd touched a 52 week high of ₹1419 and a 52 week low of ₹373.65. Titan Biotech Ltd share price today i.e. is closed at ₹980, which is -30.94% down from its 52 week high and 162.28% up from its 52 week low.
Titan Biotech Ltd market capitalisation is ₹820.38 Cr as on .
To buy Titan Biotech Ltd shares, you need to follow these steps:
Titan Biotech Ltd trading volume is 6,529.00 as on . This means that 6,529.00 shares of Titan Biotech Ltd were bought and sold on the stock market during today's trading session.